News / Korea / yonhap_finance
SkyLabs Shares Rise on KOSDAQ Debut After Early Volatility
Health Technology · Medical Specialties · yonhap_finance · 2026-09-04
386380
Medical device manufacturer SkyLabs saw its shares climb above its IPO price on its first day of trading on the KOSDAQ market.
What Happened
Market Debut: Medical device manufacturer SkyLabs successfully debuted on the KOSDAQ market, with its shares trading above the IPO price of 10,000 KRW during early morning sessions. Despite an initial dip shortly after the opening bell, the stock managed to rebound and maintain positive momentum.
Company Background: Established in 2015, SkyLabs specializes in the production of cuffless continuous blood pressure monitoring medical devices. The company is supported by Korea Investment & Securities, which served as the lead underwriter for the listing.
Financial Performance: For the previous fiscal year, the company reported consolidated revenue of 7.9 billion KRW and an operating loss of 14.7 billion KRW. These figures reflect the company's current phase of heavy investment in research and market expansion.
Investor Sentiment: The IPO process saw a competitive ratio of 63.41 to 1 during the institutional demand forecasting phase. While the stock experienced volatility upon listing, the subsequent recovery suggests ongoing interest from market participants.